Número 1 - EII al dÃa
Número 1 - EII al dÃa
Número 1 - EII al dÃa
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
Revisiones<br />
American Crohn’s Study Group Investigators. N Engl J Med<br />
2000;342:1627-32.<br />
29. Feagan BG, Rochon J, Fedorak RN et <strong>al</strong>. Methotrexate for the treatment<br />
of Crohn’s disease. The North American Crohn’s Study Group<br />
Investigators. N Engl J Med 1995;332:292-7.<br />
30. Cummings RF, Herrlinger KR, Travis SPL, Gorard DA, Mcintyre AS and<br />
Jewell DP. Or<strong>al</strong> methotrexate in ulcerative colitis. Aliment Pharmacol Ther<br />
2005;21:385-389.<br />
31. Massironi S, Losco A and Basilisco G. Drug side-effects in IBD. Aliment<br />
Pharmacol Ther 2002;16:1831<br />
32. Aith<strong>al</strong> GP, Haugk B, Das S, Card T, Burt AD and Record CO.<br />
Monitoring methotrexate-induced hepatic fibrosis in patients with<br />
psoriasis: are seri<strong>al</strong> liver biopsies justified?. Aliment Pharmacol Ther<br />
2004:19:391-399.<br />
33. Whiting-O’Keefe QE, Fye KH, Sack KD. Methotrexate and histologic<br />
hepatic abnorm<strong>al</strong>ities: a meta-an<strong>al</strong>ysis. Am J Med 1991;90:711-6.<br />
34. Marc Lémann, Taoufik Zenjari, Yoram Bouhnik, Jacques Cosnes, Bruno<br />
Mesnard, Jean-Claude Rambaud et <strong>al</strong>. Methotrexate in Crohn’s disease:<br />
long-term efficacy and toxicity. Am J Gastroenterol 2000;95(7):1730-<br />
1734.<br />
35. Ortiz Z, Shea B, Suarez-Almazor ME, Moher D, Wells GA, Tugwell P. The<br />
efficacy of folic acid and folinic acid in reducing methotrexate gastrointestin<strong>al</strong><br />
toxicity in rheumatoid arthritis. A metaan<strong>al</strong>ysis of randomized<br />
controlled tri<strong>al</strong>s. J Rheumatol 1998;25:36-43.<br />
36. Loftus EV, Kane SV, Bjorkman D. Systematic review: short-term advers<br />
effects of 5-aminos<strong>al</strong>icylic acid agents in the treatment of ulcerative colitis.<br />
Aliment Pharmacol Ther 2004;19:179-189.<br />
37. Marteau P and Cellier C. Side effects of 5-aminos<strong>al</strong>icylic acid. Gastroenterol<br />
Clin Biol 1997;21:377-86.<br />
38. Ransford RAJ,Langman MJS. Sulphas<strong>al</strong>azine an mes<strong>al</strong>azine: serious adverse<br />
reactions re-ev<strong>al</strong>uated on the basis of suspected adverse reaction<br />
reports to the Committee on Safety of Medicines. Gut 2002;51:536-539.<br />
7 • Enfermedad Inflamatoria Intestin<strong>al</strong> <strong>al</strong> día - Vol. 5 - Nº. 1 - 2006
Change language